Last reviewed · How we verify

Zurita Laboratorio Farmaceutico Ltda. — Portfolio Competitive Intelligence Brief

Zurita Laboratorio Farmaceutico Ltda. pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Benzoyl peroxide and sulfur Benzoyl peroxide and sulfur marketed Topical acne treatment combination Dermatology
Vehicle of Acnase Vehicle of Acnase phase 3
Benzoyl Peroxide 5% and Sulphur 2% Benzoyl Peroxide 5% and Sulphur 2% phase 3 Topical antimicrobial and keratolytic combination Dermatology

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. MedDerm Associates · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Zurita Laboratorio Farmaceutico Ltda.:

Cite this brief

Drug Landscape (2026). Zurita Laboratorio Farmaceutico Ltda. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/zurita-laboratorio-farmaceutico-ltda. Accessed 2026-05-18.

Related